Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine

Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine

Bibliographic Details
Main Author:	Frank S. Fan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Oncology
Subjects:	caffeine coffee hepatocellular carcinoma NLRP3 inflammasome pyroptosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1029491/full

Similar Items

Inhibition of NLRP3 inflammasome activation by caffeine might be a potential mechanism to reduce the risk of squamous cell carcinoma of the oral cavity and oropharynx with coffee drinking
by: Frank S. Fan
Published: (2022-09-01)

The role of NLRP3 inflammasome in hepatocellular carcinoma
by: Huijie Zhao, et al.
Published: (2023-04-01)

Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation
by: Shan L, et al.
Published: (2024-03-01)

Neuroprotection of Emodin by Inhibition of Microglial NLRP3 Inflammasome-Mediated Pyroptosis
by: Wen Jiang, et al.
Published: (2023-03-01)

Caffeine Has Different Immunomodulatory Effect on the Cytokine Expression and NLRP3 Inflammasome Function in Various Human Macrophage Subpopulations
by: Elek Gergő Kovács, et al.
Published: (2021-07-01)

Caffeine, coffee, and health /
by: Garattini, Silvio
Published: (1993)

Phospholipid transfer protein ameliorates sepsis-induced cardiac dysfunction through NLRP3 inflammasome inhibition
by: Wang Jian, et al.
Published: (2024-03-01)

NLRP3 inflammasome: The rising star in cardiovascular diseases
by: Yidan Zheng, et al.
Published: (2022-09-01)

Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies
by: Ioanna E. Stergiou, et al.
Published: (2024-02-01)

NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
by: Lixia Zhang, et al.
Published: (2022-09-01)

Eriodictyol inhibits the motility, angiogenesis and tumor growth of hepatocellular carcinoma via NLRP3 inflammasome inactivation
by: Wei Huang, et al.
Published: (2024-02-01)

Aerobic exercise alleviates pyroptosis-related diseases by regulating NLRP3 inflammasome
by: Shujuan Hu, et al.
Published: (2022-09-01)

NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention
by: Ping Ding, et al.
Published: (2024-04-01)

NLRP3 inflammasome-induced pyroptosis in digestive system tumors
by: Jiexia Wen, et al.
Published: (2023-04-01)

Mechanistic and therapeutic insights into the function of NLRP3 inflammasome in sterile arthritis
by: Yi Xiao, et al.
Published: (2023-10-01)

Hunting down NLRP3 inflammasome: An executioner of radiation-induced injury
by: Han Cheng, et al.
Published: (2022-10-01)

Ischemic Preconditioning Provides Neuroprotection by Inhibiting NLRP3 Inflammasome Activation and Cell Pyroptosis
by: Li Gao, et al.
Published: (2023-06-01)

Regulation and functions of the NLRP3 inflammasome in RNA virus infection
by: Zhaoyang Yue, et al.
Published: (2024-01-01)

Promiscuous Inflammasomes: The False Dichotomy of RNA/DNA Virus-Induced Inflammasome Activation and Pyroptosis
by: Hannah L. Wallace, et al.
Published: (2022-09-01)

An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
by: Aroa Baragaño Raneros, et al.
Published: (2021-11-01)

The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy
by: Yukun Liu, et al.
Published: (2022-11-01)

Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment
by: Zheng Gao, et al.
Published: (2023-05-01)

Kisspeptin Suppresses Inflammasome-NLRP3 Activation and Pyroptosis Caused by Hypothyroidism at the Maternal-Fetal Interface of Rats
by: Bianca Reis Santos, et al.
Published: (2023-04-01)

Lipocalin-2 Deficiency Diminishes Canonical NLRP3 Inflammasome Formation and IL-1β Production in the Subacute Phase of Spinal Cord Injury
by: Nina Müller, et al.
Published: (2023-05-01)

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
by: Yawen Cai, et al.
Published: (2022-01-01)

ChemR23 signaling ameliorates brain injury via inhibiting NLRP3 inflammasome-mediated neuronal pyroptosis in ischemic stroke
by: Lan Liu, et al.
Published: (2024-01-01)

Daphnetin ameliorates PM2.5-induced airway inflammation by inhibiting NLRP3 inflammasome-mediated pyroptosis in CS-exposed mice
by: Xiaoye Fan, et al.
Published: (2023-09-01)

Lactobacillus Plantarum Promotes Wound Healing by Inhibiting the NLRP3 Inflammasome and Pyroptosis Activation in Diabetic Foot Wounds
by: Wang X, et al.
Published: (2024-03-01)

TMBIM4 Deficiency Facilitates NLRP3 Inflammasome Activation-Induced Pyroptosis of Trophoblasts: A Potential Pathogenesis of Preeclampsia
by: Yuanyao Chen, et al.
Published: (2023-01-01)

Dietary disodium fumarate supplementation alleviates subacute ruminal acidosis (SARA)-induced liver damage by inhibiting pyroptosis via mitophagy-NLRP3 inflammasome pathway in lactating Hu sheep
by: Hongzhu Zhang, et al.
Published: (2023-05-01)

Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
by: Miguel A. Ortega, et al.
Published: (2023-07-01)

Microcystin-LR Induces and Aggravates Colitis through NLRP3 Inflammasome-Mediated Pyroptosis in Mice
by: Yue Yang, et al.
Published: (2023-07-01)

Inhibition of Dectin-1 Alleviates Neuroinflammatory Injury by Attenuating NLRP3 Inflammasome-Mediated Pyroptosis After Intracerebral Hemorrhage in Mice: Preliminary Study Results
by: Ding Z, et al.
Published: (2022-10-01)

Mitophagy protects against silver nanoparticle–induced hepatotoxicity by inhibiting mitochondrial ROS and the NLRP3 inflammasome
by: Jiangyan Li, et al.
Published: (2024-03-01)

Baicalein Suppresses NLRP3 and AIM2 Inflammasome-Mediated Pyroptosis in Macrophages Infected by Mycobacterium tuberculosis via Induced Autophagy
by: Bangzuo Ning, et al.
Published: (2023-06-01)

Silibinin ameliorates deoxycholic acid-induced pyroptosis in steatotic HepG2 cells by inhibiting NLRP3 inflammasome activation
by: Meiqing Mai, et al.
Published: (2023-09-01)

Aloe-Emodin Derivative, an Anthraquinone Compound, Attenuates Pyroptosis by Targeting NLRP3 Inflammasome in Diabetic Cardiomyopathy
by: Yingying Hu, et al.
Published: (2023-09-01)

TIGAR deficiency induces caspase-1-dependent trophoblasts pyroptosis through NLRP3-ASC inflammasome
by: Junjun Guo, et al.
Published: (2023-04-01)

Microtubule affinity regulating kinase 4 promoted activation of the NLRP3 inflammasome-mediated pyroptosis in periodontitis
by: Lulu Wang, et al.
Published: (2022-12-01)

Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications
by: Xiang Li, et al.
Published: (2022-10-01)